Literature DB >> 2213976

The features of sickle cell disease in Saudi children.

M A el-Hazmi1, H M Bahakim, A M al-Swailem, A S Warsy.   

Abstract

Using a prospective and retrospective approach, the features of sickle cell disease (SCD) were investigated in 137 SCD children from the south-western region of Saudi Arabia. The patients were followed for a period of 2-5 years, during which period the severity of the disease was assessed and a 'severity index', was calculated for individual patients. The patients with SCD were classified into five groups based on the absence of thalassaemia (sickle cell anaemia, SCA), presence of beta zero-thalassaemia (HbS/beta zero-thalassaemia), SCA with alpha-thalassaemia.2 [heterozygotes (-alpha/alpha alpha) or homozygotes (-alpha/alpha)] and S/beta zero-thalassaemia with alpha-thalassaemia. The results showed a high prevalence of associated alpha-thalassaemia and variable levels of HbF in these patients. SCA patients with associated alpha-thalassaemia (-alpha/-alpha) and S/beta zero-thalassaemia patients with one alpha-gene deletion had the highest values for haematological parameters and lowest values of red cell indices. No specific difference could be identified in the clinical manifestations in the different groups with the exception that long bone crisis and hand-foot syndrome were not encountered in patients with associated alpha-thalassaemia. The frequency of hepatomegaly and splenomegaly was also lower in this group.

Entities:  

Mesh:

Year:  1990        PMID: 2213976     DOI: 10.1093/tropej/36.4.148

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  7 in total

1.  Does G gamma/A gamma ratio and Hb F level influence the severity of sickle cell anaemia.

Authors:  M A el-Hazmi; H M Bahakim; A S Warsy; A al-Momen; A al-Wazzan; I al-Fawwaz; S Huraib; M Harakati
Journal:  Mol Cell Biochem       Date:  1993-07-07       Impact factor: 3.396

2.  Increased circulating levels of soluble HLA class I heterodimers in patients with sickle cell disease.

Authors:  C Moore; M Ehlayel; J Inostroza; L E Leiva; S Kuvibidila; L Yu; R Gardner; D L Ode; R Warrier; R U Sorensen
Journal:  J Natl Med Assoc       Date:  1998-03       Impact factor: 1.798

3.  Cardiac manifestations of sickle cell anaemia in Sudanese children.

Authors:  Ghada O M Ali; Yahya S Abdal Gader; Elfatih S Abuzedi; Bakhieta A I Attalla
Journal:  Sudan J Paediatr       Date:  2012

Review 4.  Piracetam for reducing the incidence of painful sickle cell disease crises.

Authors:  Amani Al Hajeri; Zbys Fedorowicz
Journal:  Cochrane Database Syst Rev       Date:  2016-02-12

Review 5.  Sickle cell disease in Middle East Arab countries.

Authors:  Mohsen A F El-Hazmi; Ali M Al-Hazmi; Arjumand S Warsy
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

6.  New mutations of locus control region in Saudi sickle patients.

Authors:  Faris Q Alenzi
Journal:  Saudi J Biol Sci       Date:  2020-01-31       Impact factor: 4.219

7.  Biochemical and Molecular analysis of the beta-globin gene on Saudi sickle cell anemia.

Authors:  Faris Q Alenzi; Dalal S AlShaya
Journal:  Saudi J Biol Sci       Date:  2019-03-15       Impact factor: 4.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.